Features & Articles
Filter By
Making Sense of Various COVID-19 Vaccine Technologies
With the delivery of the first batches of SARS-CoV-2 vaccines, providers and laypeople alike have questions about the technologies behind them. 51¾«Æ·ÊÓƵ Med magazine enlisted Jeremy Berg, 51¾«Æ·ÊÓƵ’s associate
Why We’re So Bad at Counting Calories
Counting or comparing calories across dishes and quantities is a lot harder to do than people think, found Peggy Liu, assistant professor of business administration, in a series of studies.
Students, Alumni ‘Charging’ Forward With New Phone Battery Device
Developed in a 51¾«Æ·ÊÓƵ engineering classroom, the Canal Battery Guard mediates between your phone and charger to keep the battery working better for longer.
Study Shows Genetically Engineered Mini-Livers Extend the Life of Mice With Liver Disease
The new study, led by pathologist and bioengineer Mo Ebrahimkhani, is a step toward figuring out the genes necessary to produce mature cells needed to construct a functioning liver.
Researchers Scan DNA to Learn How Facial Features Form
A new study revealed that more than 130 regions in human DNA play a role in sculpting facial features. Understanding the link between specific genes and facial features could be useful for treating
Rory Cooper Appointed Assistant Vice Chancellor for Research
Inventor and assistive technology researcher Rory Cooper will take on a first-ever role to foster collaborations between STEM disciplines and the health sciences.
On World AIDS Day, Learn About 51¾«Æ·ÊÓƵ’s Work and Impact
51¾«Æ·ÊÓƵ and 51¾«Æ·ÊÓƵsburgh have long fought HIV and AIDS. On this World AIDS Day, learn about some of the efforts to conquer the disease.
Why Do Older People Heal More Slowly?
The older you get, the more slowly you heal, and there are a number of reasons why. Matthew Steinhauser, associate professor of medicine, explains for The Conversation.
51¾«Æ·ÊÓƵsburgh Recruiting Continues for AstraZeneca Vaccine Candidate
51¾«Æ·ÊÓƵsburgh is one of more than 100 trial sites for a vaccine being developed by AstraZeneca and Oxford. The vaccine was shown to be highly effective at combating COVID-19 in a preliminary analysis.
51¾«Æ·ÊÓƵ Joins New DOE Cybersecurity Manufacturing Innovation Institute
Experts from the Swanson School of Engineering, the School of Computing and Information and the Institute for Cyber Law, Policy, and Security join a new consortium to produce methods, standards and
51¾«Æ·ÊÓƵsburgh Lends Expertise, Arms to Moderna Vaccine Development
On Monday, Moderna became the second company to announce promising early results of its Phase 3 COVID-19 vaccine trial. The 51¾«Æ·ÊÓƵsburgh site, led by 51¾«Æ·ÊÓƵ’s Judy Martin, has seen more than 250
A New Way to Look at Lung Infections—Like Rice
When sushi rice is compressed, it sticks to the food it surrounds. A new study from 51¾«Æ·ÊÓƵ engineers has found the same can be said for the mechanical properties of mucus.
51¾«Æ·ÊÓƵ research finds new green investment key to transforming regional economy
A nonpartisan team led by Leslie Marshall in 51¾«Æ·ÊÓƵ’s Center for Sustainable Business has created a roadmap for climate-friendly industrial growth over the next decade to add jobs and economic prospects
51¾«Æ·ÊÓƵ Experts Optimistic About Vaccine Candidate’s Efficacy, Advise People Continue Protecting Themselves
Four 51¾«Æ·ÊÓƵ experts offer their thoughts on Pfizer’s announcement today of a vaccine that early data show is more than 90% effective in preventing COVID-19.
Llama Nanobodies Could be a Powerful Weapon Against COVID-19
Research published today in Science describes a new method to extract tiny but extremely powerful antibody fragments from llamas, which could then be fashioned into inhalable therapeutics for COVID-19
Experts Discuss a Vaccine for COVID-19
If you missed yesterday’s panel discussion on rolling out a vaccine for COVID-19, watch the recording here, or read highlights from a wide-ranging discussion.
Innovating in a PInCh
It’s only fair that the 51¾«Æ·ÊÓƵ Innovation Challenge would itself need to innovate. Find out which projects won this year’s competition—which awarded nearly $500,000—and how participants adjusted to a
Q&A: Paul Duprex on the Promise of a COVID-19 Vaccine
51¾«Æ·ÊÓƵ’s Jonas Salk Chair for Vaccine Research explains why we need multiple candidate vaccines, what’s special about SARS-CoV-2 and why he’s hopeful about the future.
Where Does Your Swab Go After Surveillance Testing?
At 51¾«Æ·ÊÓƵ, the MiGEL Lab and its robot liquid handler play a major role in processing surveillance testing samples. Learn how samples are pooled, tested and sequenced to help in the battle against COVID
Q&A: March of Dimes Expert on a COVID-19 Vaccine Going Global
When Jonas Salk and his 51¾«Æ·ÊÓƵ team, supported by March of Dimes, tackled the polio pandemic, they came up with creative ways to make and distribute the vaccine. Dr. Rahul Gupta of March of Dimes
